Where is the superiority of proton radiation for ocular tumours?

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 240, Issue 7, 2002, Pages 513-514

  Bechrakis, Nikolaos E ^a   Foerster, Michael H ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COBALT 60;

BRACHYTHERAPY; CANCER CONTROL; CANCER LOCALIZATION; CANCER SIZE; CANCER SURVIVAL; EDITORIAL; EYE TUMOR; HUMAN; MORBIDITY; OPTIC DISK; OPTIC NERVE DISEASE; PRIORITY JOURNAL; PROTON RADIATION; RADIATION DOSE FRACTIONATION; RADIATION FIELD; RETINA FOVEA; RETINOPATHY; TREATMENT PLANNING; UVEA TUMOR; VISION;

EID: 0036946514     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-002-0491-x     Document Type: Editorial

References (12)

1. Augsburger JJ, Lauritzen K, Gamel JW, DeBrakeleer DJ, Lowry JC, Eisenman R (1990) Matched group study of surgical resection versus cobalt-60 plaque radiotherapy for primary choroidal or ciliary body melanoma. Ophthalmic Surg 21: 682-688
2. Bechrakis NE, Bornfeld N, Zoller I, Foerster MH (2001) Iodine-125 brachytherapy and trans-scleral tumor resection in large uveal melanomas. Ophthalmologe 98: 736-742
3. Char DH, Quivey JM, Castro JR, Kroll S, Phillips T (1993) Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma. A prospective, randomized, dynamically balanced trial. Ophthalmology 100: 1547-1554
4. Egan KM, Gragoudas ES, Seddon JM, Glynn RJ, Munzenreider JE, Goitein M, Verhey L, Urie M, Koehler A (1989) The risk of enucleation after proton beam irradiation of uveal melanoma. Ophthalmology 96: 1377-1382; discussion 1382-1383
5. Egger E, Schalenbourg A, Zografos L, Bercher L, Boehringer T, Chamot L, Goitein G (2001) Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma. Int J Radiat Oncol Biol Phys 51: 138-147
6. Foss AJ, Whelehan I, Hungerford JL, Anderson DF, Errington RD, Kacperek A, Restori M, Kongerud J, Sheen M (1997) Predictive factors for the development of rubeosis following proton beam radiotherapy for uveal melanoma. Br J Ophthalmol 81: 748-754
7. Gragoudas ES (1997) 1996 Jules Gonin Lecture of the Retina Research Foundation. Long-term results after proton irradiation of uveal melanomas. Graefes Arch Clin Exp Ophthalmol 235: 265-267
8. Gragoudas ES, Goitein M, Koehler AM, Verhey L, Tepper J, Suit HD, Brockhurst R, Constable IJ (1977) Proton irradiation of small choroidal malignant melanomas. Am J Ophthalmol 83: 665-673
9. Joiner MC (1997) Hyperfractionation and accelerated radiotherapy. In: Steel GG (ed) Basic clinical radiobiology. Arnold, London, pp 123-131
10. Lumbroso L, Desjardins L, Levy C, Plancher C, Frau E, D'Hermies F, Schlienger P, Mammar H, Delacroix S, Nauraye C, et al (2001) Intraocular inflammation after proton beam irradiation for uveal melanoma. Br J Ophthalmol 85: 1305-1308
11. Seddon JM, Gragoudas ES, Polivogianis L, Hsieh CC, Egan KM, Goitein M, Verhey L, Munzenrider J, Austin-Seymour M, Urie M, et al. (1986) Visual outcome after proton beam irradiation of uveal melanoma. Ophthalmology 93: 666-674
12. Wilson MW, Hungerford JL (1999) Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma. Ophthalmology 106: 1579-1587